Baycip-TZ consists of Ciprofloxacin, Tinidazole.
Indication: For the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections (used in combination with metronidazole), infectious diarrhea, typhoid fever (enteric fever), uncomplicated cervical and urethral gonorrhea, and inhalational anthrax (post-exposure).
Baycip-TZ (Ciprofloxacin) is a broad-spectrum antiinfective agent of the fluoroquinolone class. Baycip-TZ (Ciprofloxacin) has in vitro activity against a wide range of gram-negative and gram-positive microorganisms. The mechanism of action of quinolones, including ciprofloxacin, is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, organisms resistant to these drugs may be susceptible to ciprofloxacin. There is no known cross-resistance between Baycip-TZ (Ciprofloxacin) and other classes of antimicrobials. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian.
Tinidazole - A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections. Indication: For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age. Baycip-TZ (Tinidazole) is a synthetic antiprotozoal agent. Baycip-TZ (Tinidazole) demonstrates activity both in vitro and in clinical infections against the following protozoa: Trichomonas vaginalis, Giardia duodenalis (also termed G. lamblia), and Entamoeba histolytica. Baycip-TZ (Tinidazole) does not appear to have activity against most strains of vaginal lactobacilli.
Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products: Ciprofloxacin Tinidazole Baycip-TZ available forms, composition, doses: Tablets; Oral; Ciprofloxacin 500 mg; Tinidazole 600 mg
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.